Advisory - Alesse 21 and 28 birth control pill: Packages may contain broken or smaller-than-normal pills, which may reduce effectiveness in preventing pregnancy
OTTAWA, Dec. 1, 2017 /CNW/ -
Issue Health Canada is advising consumers and health care professionals that complaints have been received for packages of Alesse 21 (21 active pills) and Alesse 28 (21 active pills, 7 that contain no hormones). The blister packages for both contained an active (pink) pill that was roughly half the proper size.
Alesse 21 and Alesse 28 are prescription drugs used to prevent pregnancy.
Who is affected
Women who are currently taking Alesse 21 or Alesse 28
Health professionals who dispense these products
Affected products
Alesse 21 and Alesse 28. The complaints involved packages from the following lots, but it is not known at this time whether the issue is isolated to these lots:
Alesse 21 (DIN 02236974) Lot A2532, expires August 2018
Alesse 28 (DIN 02236975) Lot A3183, expires April 2019
What consumers should do
Check your pills before and after taking them out of the blister package. Do not consume a pill if it looks unusual. Examine both sides of each pill thoroughly for anything unusual before taking it (such as, a different (paler) colour, jagged edges, or the pill is broken or smaller than normal). It may not be immediately obvious from looking at the blister package that there is a problem with the pills, as the underside of the pill cannot be seen while in the blister pack.
If you have a package with an unusual pill, return it to your pharmacy for a replacement package.
Do not stop taking your birth control pills as this may result in pregnancy. If you have questions or concerns about your birth control product, talk to a health care professional, including about alternatives. Talk to a health care professional if you have any questions or concerns about your birth control product.
Report adverse events to health products to Health Canada by calling toll-free at 1?866?234?2345, or by reporting online, by mail or by fax.
Report complaints about health products to Health Canada by calling toll-free at 1?800?267?9675, or complete an online complaint form.
Additional information for pharmacists:
Check each blister pack of Alesse 21 and Alesse 28 before dispensing it to make sure the pills look as they should.
Background Broken or smaller-than-normal birth control pills may deliver a smaller dose of the active drug ingredient, which could reduce its effectiveness in preventing pregnancy.
What Health Canada is doing Health Canada is working with the company, Pfizer Canada, to determine the nature and scope of the issue. We will continue to monitor the situation and assess the need for further action. Health Canada will update consumers and health care professionals as appropriate.
For more information Stay connected with Health Canada and receive the latest advisories and product recalls using social media tools.
Neurent Medical, a company pioneering innovative non-surgical interventions to treat chronic inflammatory sinonasal diseases, today announced the appointment of Mr. John Peterson as the new Vice President of Sales & Marketing, effective immediately....
Endoscopy Equipment Market in terms of revenue was estimated to be worth $32.3 billion in 2024 and is poised to reach $46.2 billion by 2029, growing at a CAGR of 7.4% from 2024 to 2029 according to a new report by MarketsandMarketstm. The growth in...
Integrity Marketing Group, LLC ("Integrity"), one of the leading independent distributors of life, health and wealth products, today announced that Integrity Co-Founder and CEO Bryan W. Adams has been recognized as a top CEO for large companies in...
On March 28, 2024, Broncus Medical (02216.HK) (the "Company" or "we" ) announced annual results for FY 2023.
In 2023, Broncus Medical earned product sales of US$12.41 million, an increase of 32% compared to the previous year. Of which, total revenue...
In a groundbreaking leap forward in the realm of nutrition and fitness technology, Portions Master announces the launch of its revolutionary app, set to transform the way individuals approach portion control and nutritional tracking....
Highlights of the Annual Results as of December 31, 2023:
Revenue reached RMB2,155.6 millionGross profit amounted to RMB738.5 millionAdjusted non-IFRS net loss improved to RMB208.8 million, representing a significant turnaround from a negative...